PFCS
IRON icon

Pale Fire Capital SE’s Disc Medicine IRON Stock Holding History

Pale Fire Capital SE’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,609
Closed -$325K – 59
2024
Q3 		$325K Buy
+6,609
New +$310K 0.05% 32
2024
Q1 		– Sell
-6,120
Closed -$353K – 65
2023
Q4 		$353K Buy
+6,120
New +$313K 0.06% 41

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pale Fire Capital SE's IRON Position: Q4 2024 in Review

Pale Fire Capital SE sold out of Disc Medicine (IRON) in Q4 2024, closing a stake of 6,609 shares — an estimated $325K sold.

Pale Fire Capital SE first reported a position in IRON in Q4 2023 and held it in 2 quarters. The position peaked at $353K in Q4 2023. 152 funds tracked by Wall St. Rank hold IRON as of Q4 2024.

  • Pale Fire Capital SE reported no remaining Disc Medicine position as of Q4 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 6,609 Disc Medicine shares in Q4 2024, an estimated $325K.
  • Pale Fire Capital SE first reported a position in Disc Medicine in Q4 2023 and held it in 2 quarters.
  • Pale Fire Capital SE's Disc Medicine position peaked at $353K in Q4 2023.
  • 152 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2024.

Based on Pale Fire Capital SE's 13F filing for Q4 2024, filed 13 Feb 2025.